It was revealed on the 11th that Yonsei University Health카지노 System was ranked 78th and the only university hospital in Korea to be included in the ‘Top 100 Leading Cancer Research Medical Institutions in the World’ selected by the international academic journal Nature on the 6th (local time). Among the so-called Big Five, Asan Medical Center, Yonsei Severance Hospital, Seoul National University Hospital, Samsung Seoul Hospital, and Seoul St. Mary’s Hospital, only Yonsei Medical Center was named. The University of Texas MD Anderson Cancer Center ranked first, followed by Memorial Sloan Kettering Cancer Center ( MSKCC ) in second place, and the University of Texas Southwestern Medical Center ( UT Southwestern Medical Center) in third place.
Nature ranked excellent papers published in 68 renowned academic journals from 2018 to 2022, taking into account each author’s affiliation and co-authorship contribution. For example, papers written by authors belonging to more than one institution are scored equally. MD
Anderson Cancer Center, which ranked first, published 116 cancer-related research papers written during this period. Although the number of papers was small compared to the Dana-Farber Cancer Center in the United States (1,281), the paper score was overwhelmingly high at 320.86. Memorial Sloan Kettering Cancer Center, which ranked second, and the University of Texas Southwestern Medical Center, which ranked third, had a low absolute number of papers (963 and 483, respectively), but their paper scores were high at 280.90 and 217.99.
American medical institutions swept from 1st to 14th place. When analyzing the 100 medical institutions by country, the United States had the largest number with 46, followed by China with 21, the Netherlands with 8, Germany with 7, Switzerland with 3, France with 2, Spain with 2, and Singapore with 1.
Among medical institutions outside the United States, the National University Hospital of Milan, Italy’s Institute of Clinical Health and Medical Sciences ( IRCCS ) ranked 15th, China’s Shanghai Jiaotong Medical University-affiliated Renzi Hospital (16th), and Canada’s University of Toronto Medical School Research Network Hospital UHN (17th) ranked in the top 20. included. IRCCS ‘ paper scores remained in the 40-50 range until 2021, but more than doubled to 106.57 last year.
Among domestic medical institutions, Yonsei University Health System ( YUHS ) ranked 78th with 17.94 points. Although the number of research papers was the lowest (94th) with 74, the paper score was high. The Big 5 hospitals, including Samsung Seoul Hospital, Seoul National University Hospital, and Seoul Asan Medical Center, were all excluded.
The medical community explains that the reason domestic university hospitals, known as leaders in cancer treatment, lag behind medical institutions in the U.S. and Europe in terms of research performance is due to the reality of domestic university hospitals having to treat patients and conduct clinical trials and research in parallel. “Basic research and clinical research are often conducted separately by academics,” said Lee Se-hoon, academic director of the Korean Society of Medical Oncology and professor of hematology and oncology at Samsung Seoul Hospital. “In Korean university hospitals, professors see patients, do clinical work, and conduct research.” “I do it,” he explained.
However, some argue that the fact that Yonsei Medical Center was ranked ahead of other institutions was an error in the criteria for classifying each institution. In Nature, Yonsei Medical Center includes Gangnam Severance Hospital, Severance Hospital (Sinchon), and Yongin Severance Hospital, and Seoul National University Hospital ( SNUH ) includes only Seoul National University Main Hospital, Seoul National University Cell Therapy Research Institute, and Boramae Hospital and Seoul National University Children’s Hospital. This means that papers from Seoul National University Bundang Hospital are omitted from the performance of Seoul National University Hospital.
On the same day, Nature also ranked 200 universities researching cancer, and in the rankings by university, Seoul National University ranked 58th and was the only one in the top 100. Yonsei University was ranked 111th. Seoul National University’s performance includes the Seoul National University Convergence Technology Institute, Seoul National University Bundang Hospital, Seoul National University Hospital, and Seoul National University’s Soft Robotics and Biomedical Engineering Laboratory. However, looking at the combined score of separate thesis performance from 2018 to 2022, even Seoul National University Hospital (35.72) and Seoul National University Bundang Hospital (10.6) combined could not catch up with Yonsei Medical Center’s score (55.05).
In this announcement, Samsung Group was ranked 22nd among 25 leading companies in cancer research. Roche of Switzerland ranked 1st, followed by Novartis of Switzerland in 2nd place, AstraZeneca of the UK in 3rd place, Pfizer of the US in 4th place, and Bristol Myers Squibb ( BMS ) in 5th place.
The institutions with which Samsung collaborated the most in research domestically were Sungkyunkwan University, Samsung Seoul Hospital, and Seoul National University, and overseas, they were Stanford University, University of Toronto, Harvard University, and Massachusetts Institute of Technology (MIT ) . Samsung Group’s scores are Samsung Electronics and Samsung SDS ., Cheil Industries, Samsung Seoul Hospital, and Samsung-Sungkyunkwan Graphene Center are all included.